Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Azenta, Inc. - Common Stock (NQ: AZTA )

36.56 -1.64 (-4.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 951,895
Open 37.65
Bid (Size) 14.76 (2)
Ask (Size) 39.70 (1)
Prev. Close 38.20
Today's Range 35.90 - 38.71
52wk Range 37.71 - 65.29
Shares Outstanding 12,500,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Azenta (NASDAQ:AZTA) and its peers. 
Via StockStory

Performance

YTD
-26.94%
-26.94%
1 Month
-23.05%
-23.05%
3 Month
-20.37%
-20.37%
6 Month
-20.68%
-20.68%
1 Year
-43.48%
-43.48%

More News

Read More
1 Small-Cap Stock with Exciting Potential and 2 to Brush Off
Via StockStory
Topics Supply Chain
Exposures Supply Chain
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Via StockStory
A Glimpse Into The Expert Outlook On Azenta Through 4 Analysts
Via Benzinga
Earnings Scheduled For February 5, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
Via StockStory
What To Expect From Fortrea’s (FTRE) Q4 Earnings
Via StockStory
UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings
Via StockStory
Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow
Via StockStory
A Look Ahead: Azenta's Earnings Forecast
Via Benzinga
Decoding 5 Analyst Evaluations For Azenta
Via Benzinga
The Analyst Landscape: 7 Takes On Azenta
Via Benzinga
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow
Via StockStory
West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For
Via StockStory
Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Azenta’s (NASDAQ:AZTA) Q4 Sales Top Estimates
Via StockStory
Illumina (ILMN) Reports Earnings Tomorrow: What To Expect
Via StockStory
Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday?
Via Benzinga
IQVIA (IQV) Q4 Earnings Report Preview: What To Look For
Via StockStory
Quantum Computing, BlackBerry And Lucid Group Are Among Top Mid Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
AZTA Stock Earnings: Azenta Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Robotics Stocks
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.